Archbishop Tutu calls on Obama to lead the world in expansion of HIV treatment

NewsGuard 100/100 Score

Nobel Peace Prize winner and human rights advocate Archbishop Desmond Tutu writes in a Washington Post opinion piece that President Barack Obama "is in a position to make a game-changing impact on the war against AIDS" and he "should lead the world in a massive effort to expand access to treatment and rid humanity of AIDS -- the most devastating disease of our time." However, "just as the end of AIDS has finally come within reach, we are witnessing an unprecedented drop in financial and political support for the cause," he adds.

"Obama should increase PEPFAR's treatment goal from four million to six million people by 2013. He should then issue a challenge to other leaders -- of donor nations and those countries most affected by HIV/AIDS -- to scale up their contributions," he writes, concluding that with "the world finally possess[ing] affordable tools and scientific knowledge that could stop HIV/AIDS in its tracks," Obama "must take" this "profound opportunity" (9/20).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Common HIV drugs linked to reduced Alzheimer's disease risk